Boston Scientific's modular, wireless heart rhythm implant approach clears clinical study chale Mon, 05/20/2024 - 10:08

Gilead's new liver disease med continues to deliver the goods ahead of FDA verdict jwaldron Mon, 05/20/2024 - 06:51

Taking on pharma giants, Endeavor links IPF drug to improved lung function in phase 2 ntaylor Mon, 05/20/2024 - 05:57

Third Rock, J&J neuroscience spinout Rapport is first biotech to outline summer IPO plans jwaldron Mon, 05/20/2024 - 05:14

Vicore's bet pays off as pulmonary fibrosis drug improves lung function in phase 2 jwaldron Fri, 05/17/2024 - 09:33

R3 Vascular raises $87M to test its bioresorbable scaffold for blocked arteries below the knee chale Fri, 05/17/2024 - 11:31